Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - diclofenacum natricum, misoprostolum - compresse - a) kern: diclofenacum natricum 75 mg, lactosum monohydricum 19.5 mg, cellulosum microcristallinum, maydis amylum, povidonum k 30, magnesii stearas, Überzug: acidi methacrylici copolymerum c, natrii hydroxidum, talcum, triethylis citras, pro compresso obducto corresp. natrium 5.46 mg. b) mantel: misoprostolum 0.2 mg, hypromellosum, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, ricini oleum hydrogenatum, talcum, pro compresso. - steroideo - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - pantoprazolum - compresse rivestite con film - pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, mannitolum, crospovidonum, natrii carbonas, sorbitolum 18 mg, calcii stearas, hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, natrii laurilsulfas, polysorbatum 80, talcum, macrogolum 6000, pro compresso obducto corresp. natrium 3.4 mg. - ulcustherapie, refluxoesophagitis, sindrome di zollinger-ellison-syndrom - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - pantoprazolum - compresse rivestite con film - pantoprazolum 40 mg ut pantoprazolum natricum sesquihydricum, mannitolum, crospovidonum, natrii carbonas, sorbitolum 36 mg, calcii stearas, hypromellosum, povidonum k 25, e 171, e 172 (flavum), propylenglycolum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, natrii laurilsulfas, polysorbatum 80, talcum, macrogolum 6000, pro compresso obducto corresp. natrium 6.8 mg. - ulcustherapie, refluxoesophagitis, sindrome di zollinger-ellison-syndrom - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - telmisartanum - compresse - telmisartanum 40 mg, natrii hydroxidum corresp. natrium 1.931 mg, megluminum, povidonum k 25, lactosum monohydricum 37.2 mg, povidonum k 30, crospovidonum, lactosum 118.04 mg, magnesii stearas, pro compresso. - antihypertensivum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - telmisartanum - compresse - telmisartanum 80 mg, natrii hydroxidum corresp. natrium 3.863 mg, megluminum, povidonum k 25, lactosum monohydricum 74.4 mg, povidonum k 30, crospovidonum, lactosum 236.080 mg, magnesii stearas, pro compresso. - antihypertensivum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - celecoxibum - capsule rigide - celecoxibum 100 mg, lactosum monohydricum 16.9 mg, hydroxypropylcellulosum, crospovidonum, povidonum k 29-32, natrii laurilsulfas corresp. natrium 0.32 mg, magnesii stearas, kapselhülle: e 171, gelatina, pro capsula. - inibitore selettivo cox-2 inibitori - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - celecoxibum - capsule rigide - celecoxibum 200 mg, lactosum monohydricum 33.8 mg, hydroxypropylcellulosum, crospovidonum, povidonum k 29-32, natrii laurilsulfas corresp. natrium 0.65 mg, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, gelatina, pro capsula. - inibitore selettivo cox-2 inibitori - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - capsule - levodopum 200.0 mg, benserazidum 50.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbo di parkinson, delle gambe senza riposo-syndrom - synthetika